[VIDEO] Voices of Choice - Brad from San Francisco on Being in the iPrEx Open Label PrEP Trial

"I fell in love with someone who is HIV-positive..."

In the video below, Brad from San Francisco discusses his participation in the iPrEx Open Label Study and taking Truvada as a way to prevent HIV infection.

The iPrEx trial was the first study to show that an antiretroviral drug (ARV) - normally used to treat people living with HIV - could also be used to prevent HIV among people who are HIV-negative.

In July of 2012, the FDA approved the ARV drug Truvada for the prevention of HIV.